OQS
ADMA icon

Occudo Quantitative Strategies’s ADMA Biologics ADMA Stock Holding History

Occudo Quantitative Strategies’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-11,453
Closed -$75.6K – 724
2024
Q1 		$75.6K Sell
11,453
-187,368
-94% -$1.02M 0.01% 676
2023
Q4 		$899K Buy
+198,821
New +$736K 0.12% 235
2023
Q3 		– Sell
-141,556
Closed -$522K – 932
2023
Q2 		$522K Buy
141,556
+26,862
+23% +$99.6K 0.05% 538
2023
Q1 		$380K Sell
114,694
-33,080
-22% -$114K 0.03% 591
2022
Q4 		$573K Sell
147,774
-96,102
-39% -$296K 0.07% 459
2022
Q3 		$593K Buy
243,876
+208,757
+594% +$501K 0.05% 603
2022
Q2 		$70K Buy
+35,119
New +$69.1K 0.01% 1044

Other funds holding ADMA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $653B AUM 32.41% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return